We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 9,774 results
  1. CXCR4

    Reference work entry 2024
  2. Interplay between androgen and CXCR4 chemokine signaling in myelin repair

    In men, reduced levels of testosterone are associated with the prevalence and progression of multiple sclerosis (MS), a chronic and disabling...

    Narimène Asbelaoui, Charly Abi-Ghanem, ... Abdel Mouman Ghoumari in Acta Neuropathologica Communications
    Article Open access 30 January 2024
  3. CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study

    Controversial data have been reported on the prognostic value of C-X-C motif chemokine receptor 4 (CXCR4) in chronic lymphocytic leukemia (CLL). This...

    **nran Xue, Zhihao Wen, ... Hongyan Liao in Genes & Immunity
    Article 17 February 2024
  4. CXCL12–CXCR4 Axis in Cancer Metastasis

    The malignancy that leads to the most fatalities is characterized by metastasis. Due to continually develo** research in the biology of cancer as...
    Manzoor Ahmad Mir, Ab Qayoom Naik, ... Tabassum Zafar in Cytokine and Chemokine Networks in Cancer
    Chapter 2023
  5. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients

    Background

    Tregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in...

    Sara Santagata, Giuseppina Rea, ... Stefania Scala in British Journal of Cancer
    Article Open access 04 May 2024
  6. Demethylation in promoter region of severely damaged hepatocytes enhances chemokine receptor CXCR4 gene expression

    The liver is known to possess remarkable regenerative potential, but persistent inflammation or severe acute injury can lead to liver fibrosis and...

    Chihiro Ito, Ryuma Haraguchi, ... Sohei Kitazawa in Histochemistry and Cell Biology
    Article 02 August 2023
  7. Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV

    Neural damage due to inflammatory activation of macrophages and microglia is a consequence of HIV infection that leads to cognitive dysfunction. The...

    Kimberly S. Williams, Jaimie A. Seawell, ... Rick B. Meeker in Journal of NeuroVirology
    Article 31 May 2024
  8. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

    Background

    Although trastuzumab and other HER2-targeted therapies have significantly improved survival in patients with HER2 overexpressed or...

    Shuying Liu, Shelly M. **e, ... Debasish Tripathy in Breast Cancer Research
    Article Open access 06 June 2023
  9. Activation of the CXCR4 Receptor by Chemokine CXCL12 Increases the Excitability of Neurons in the Rat Central Amygdala

    Primarily regarded as immune proteins, chemokines are emerging as a family of molecules serving neuromodulatory functions in the develo** and adult...

    Joanna Ewa Sowa, Krzysztof Tokarski, Grzegorz Hess in Journal of Neuroimmune Pharmacology
    Article 02 March 2024
  10. CXCR4 as possible druggable target linking inflammatory bowel disease and Parkinson's disease

    Parkinson’s disease (PD) is a chronic, progressive, and second most prevalent neurological disorder affecting the motor system. It has been found...

    Nitu Dogra, Ruchi Jakhmola-Mani, ... Deepshikha Pande Katare in Metabolic Brain Disease
    Article 19 January 2023
  11. Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4

    Background:

    Antibodies and derivative drugs targeting immune checkpoints have been approved for the treatment of several malignancies, but there are...

    Shuai Hao, Shuyi Xu, ... Mingyuan Wu in BMC Cancer
    Article Open access 25 October 2022
  12. Maintenance of Epstein-Barr virus latency through interaction of LMP2A with CXCR4

    Epstein-Barr virus (EBV) belongs to the subfamily Gammaherpesvirinae and was the first human tumor virus to be discovered. The global rate of EBV...

    Ni Qin, Yan Zhang, ... Bing Luo in Archives of Virology
    Article 25 June 2022
  13. Genotype–phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variants

    Warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome is a rare primary immunodeficiency predominantly caused by heterozygous...

    Katarina Zmajkovicova, Sumit Pawar, ... Adriana Badarau in Genes & Immunity
    Article Open access 12 September 2022
  14. PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4

    Patients presenting with metastatic hepatoblastoma have limited treatment options and survival rates as low as 25%. We previously demonstrated that...

    Raoud Marayati, Janet Julson, ... Elizabeth A. Beierle in Clinical & Experimental Metastasis
    Article 31 October 2022
  15. CXCR4 enhances the inhibitory effects of bone mesenchymal stem cells on lung cell apoptosis in a rat model of smoking-induced COPD

    Chronic obstructive pulmonary disease is the 3rd leading cause of death worldwide, and the available treatments are unsatisfactory, resulting in a...

    Jiansheng Gao, Yuli Liang, ... Hua Liu in Apoptosis
    Article 31 January 2023
  16. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis

    Background

    The C-X-C chemokine receptor 4 (CXCR4) has been suggested to play an important role in several types of cancers and is related to...

    Li** Qiu, Yuanyuan Xu, ... Biyun Yu in BMC Cancer
    Article Open access 21 June 2022
  17. MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis

    Background

    Small cell lung cancer (SCLC) is an aggressive lung cancer subtype that is associated with high recurrence and poor prognosis. Due to lack...

    Parvez Khan, Jawed Akhtar Siddiqui, ... Mohd Wasim Nasser in Molecular Cancer
    Article Open access 04 January 2023
  18. Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies

    Background

    Papillary and follicular thyroid carcinomas can be treated surgically and with radioiodine therapy, whereas therapeutic options for...

    Max Czajkowski, Daniel Kaemmerer, ... Amelie Lupp in BMC Cancer
    Article Open access 07 July 2022
  19. Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma

    Temozolomide (TMZ) monotherapy is known to be insufficient for resistant/relapsed glioblastoma (GBM), thus seeking a sensitization agent for TMZ is...

    I.-Tsang Chiang, Yu-Chang Liu, ... Fei-Ting Hsu in Neurotherapeutics
    Article 10 March 2022
  20. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma

    Background

    Therapy resistance, which leads to the development of loco-regional relapses and distant metastases after treatment, constitutes one of the...

    Elisa Rioja-Blanco, Irene Arroyo-Solera, ... Ramon Mangues in Journal of Experimental & Clinical Cancer Research
    Article Open access 04 February 2022
Did you find what you were looking for? Share feedback.